ARCHIVES

How Construction Grantees Will Spend Their $30 Million

This article is from The Cancer Letter archive.

Vol. 01 No. 37 | September 12, 1975

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

Construction Not Dead After All; DCPC Board Okays Architect/ Engineering Support Contract

February 13, 1987

AZT Trial Unblended, Controls Get Drugs; Gallo, Essex Win Lasker With Montagnier

September 26, 1986

Program Project Payline Is 125; Budget Cuts Will Allow NCI To Fund 49 Competing P01s

February 28, 1992

In Brief: Discoverer Of H. Pylori Role In Ulcers Wins Lasker Foundation Clinical Research Award

October 6, 1995

Rituximab Prolonged Survival Of CLL In Phase III Study

September 24, 2010